All Resources

Allergy Outcomes Tool: PAQLQ

Allergy Outcomes Tool: PAQLQ
Allergy Outcomes Tool: PAQLQ

April 16, 2021

Pediatric allergic disease quality of life questionnaire (PAQLQ)

Description

Assesses for allergic disease that encompasses its effects on a child’s or teenager’s eyes, ears, nose, lungs, skin, emotions, and everyday activities

Targeted Age

Pediatrics

Items (domains)

26 (3)

Estimated Completion Time

10-15 minutes

Reliability/Validity Assessment

Yes/Yes

Literature

1) Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol. 2003;111:491-7.

2) Roberts G, Mylonopoulou M, Hurley C, Lack G. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy. 2005 Oct;35:1295-300.

Related Content

Rhinology Outcome Tool: RSOM-31

Research Outcome Tools

Rhinosinusitis Outcome Measure (RSOM-31)DescriptionMeasure of rhinosinusitis health status and quality of lifeTargeted AgeAdultsItems (Domains)31 (7)Estimated …

Rhinology Outcome Tool: RSUI

Research Outcome Tools

Rhinitis Symptom Utility Index (RSUI)DescriptionMeasures the severity and frequency of rhinitis related symptoms over 14 daysTargeted AgeAdultsItems (Domains)1…

Rhinology Outcome Tool: SN-5

Research Outcome Tools

Sinus and Nasal Quality of Life Survey (SN-5)DescriptionAssesses health-related quality of life for children with persistent sinonasal symptomsTargeted AgePedi…

No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.